News | November 13, 2023
Granules India Q2 FY24 PAT drops 30% at Rs. 102 Cr
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
Lack of technology transfer stands out as a formidable barrier
The plant has a capacity for extraction of 2500 mt of poppy straw and 300 mt poppy gum per year
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Increased capability to produce medicines for challenging diseases including cancer
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Subscribe To Our Newsletter & Stay Updated
